The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease

Therapeutic donor lymphocyte infusions (tDLI) are used to reinforce the graft-versus-leukemia (GvL) effect in relapse after allogeneic stem cell transplantation (alloSCT). In contrast, the role of prophylactic DLI (proDLI) in preventing leukemia relapse has been less clearly established, although su...

Descripción completa

Detalles Bibliográficos
Autores principales: Stadler, Michael, Hambach, Lothar, Dammann, Elke, Diedrich, Helmut, Kamal, Haytham, Hamwi, Iyas, Schultze-Florey, Christian, Varvenne, Michael, Ehrlich, Steve, Buchholz, Stefanie, Koenecke, Christian, Beutel, Gernot, Weissinger, Eva M., Krauter, Jürgen, Eder, Matthias, Hertenstein, Bernd, Ganser, Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444690/
https://www.ncbi.nlm.nih.gov/pubmed/37490114
http://dx.doi.org/10.1007/s00277-023-05276-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444690/
https://www.ncbi.nlm.nih.gov/pubmed/37490114
http://dx.doi.org/10.1007/s00277-023-05276-5

Ejemplares similares